Skip to content

The effectiveness of Mediclore on epididymectomy: multi-center, prospective randomized controlled, single blinded trial

The effectiveness of Mediclore on epididymectomy: multi-center, prospective randomized controlled, single blinded trial.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0003055
Enrollment
66
Registered
2018-07-31
Start date
2016-01-20
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Experimental group After epididymectomy, 3cc of Mediclore® is applied to the exposed testis and vaginalis. Control group Does not apply anti-adhesion agent after epididymectomy.

Sponsors

Hanyang University Guri Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Men over 20 years of age who can participate during the clinical trial 2) The patient was diagnosed with unilateral chronic epididymitis and treated with antibiotics, analgesic treatment for 4 weeks and cord block was performed but there was no improvement in pain 3) who signed the test subject's written consent to participate in the study 4) Patients who did not have clinically significant abnormal findings on preoperative examination

Exclusion criteria

Exclusion criteria: 1) Participate in other clinical trials within one month before enrollment in this trial 2) Have previously undergone scrotal surgery to expose the testicles or spermatic cord. 3) Patients who had urinary tract infection 4) Bilateral epididymitis 5) Chronic prostatitis or chronic pelvic pain syndrome 6) Epididymal cyst or granuloma 7) Patients who are unable to use approved methods of contraception during the trial

Design outcomes

Primary

MeasureTime frame
visual analogue pain scale

Secondary

MeasureTime frame
visual analogue pain scale;satisfaction to surgery

Countries

Korea, Republic of

Contacts

Public ContactSeung Wook Lee

Hanyang University

swleepark@gmail.com+82-31-560-2372

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026